Martha Pease Net Worth

The estimated Net Worth of Martha Pease is at least $348 Mille dollars as of 24 September 2020. Ms. Pease owns over 20,000 units of Biosig Technologies Inc stock worth over $13,188 and over the last 5 years she sold BSGM stock worth over $0. In addition, she makes $335,300 as Independent Director at Biosig Technologies Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Pease BSGM stock SEC Form 4 insiders trading

Martha has made over 6 trades of the Biosig Technologies Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 20,000 units of BSGM stock worth $8,960 on 24 September 2020.

The largest trade she's ever made was exercising 20,000 units of Biosig Technologies Inc stock on 24 September 2020 worth over $8,960. On average, Martha trades about 3,680 units every 39 days since 2019. As of 24 September 2020 she still owns at least 29,437 units of Biosig Technologies Inc stock.

You can see the complete history of Ms. Pease stock trades at the bottom of the page.

Martha Pease biography

Martha Pease serves as Independent Director of the Company. Ms. Pease was appointed to the Board on September 24, 2019. Ms. Pease brings over 30 years of recognition and experience leading organizations in brand building, customer centric growth strategy and digital leverage to increase shareholder value. Most recently, Ms. Pease has served as partner and director at BCG (Boston Consulting Group) focused on growth strategy and digital transformation with an emphasis on the healthcare sector. From 2008 to 2016, Ms. Pease served as chief executive officer, co-founder of DemandWerks LLC. Across a range of executive roles, Ms. Pease has spearheaded major equity building initiatives for companies including Neutrogena, Domino’s, Lifetime TV, L’Oreal Paris, Pizza Hut and Lane Bryant. She has served as a board director for Fetch Technologies (1995-2005), Magnetique (2010-2012) and DemandWerks (2010-2016). An on-air and online commentator for CNN, she analyzes the impact of breaking news on perceptions and leadership. Ms. Pease holds a BA, with High Honors, in English Literature and Film History from Dartmouth College, and is a graduate of the Harvard Radcliffe Publishing Procedures Course at Harvard University.

What is the salary of Martha Pease?

As the Independent Director of Biosig Technologies Inc, the total compensation of Martha Pease at Biosig Technologies Inc is $335,300. There are 5 executives at Biosig Technologies Inc getting paid more, with Kenneth Londoner having the highest compensation of $5,034,850.

How old is Martha Pease?

Martha Pease is 62, she's been the Independent Director of Biosig Technologies Inc since 2019. There are 6 older and 6 younger executives at Biosig Technologies Inc. The oldest executive at Biosig Technologies Inc is Dr. Budimir S. Drakulic Ph.D., 71, who is the Chief Scientist.

What's Martha Pease's mailing address?

Martha's mailing address filed with the SEC is C/O BIOSIG TECHNOLOGIES, INC., 54 WILTON ROAD, 2ND FLOOR, WESTPORT, CT, 06880.

Insiders trading at Biosig Technologies Inc

Over the last 9 years, insiders at Biosig Technologies Inc have traded over $1,778,587 worth of Biosig Technologies Inc stock and bought 1,345,515 units worth $2,296,289 . The most active insiders traders include Kenneth L Londoner, Asher Holzer e Jerome B Zeldis. On average, Biosig Technologies Inc executives and independent directors trade stock every 24 days with the average trade being worth of $11,433. The most recent stock trade was executed by Kenneth L Londoner on 13 June 2023, trading 15,600 units of BSGM stock currently worth $19,344.

What does Biosig Technologies Inc do?

biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.

Complete history of Ms. Pease stock trades at Biosig Technologies Inc

Biosig Technologies Inc executives and stock owners

Biosig Technologies Inc executives and other stock owners filed with the SEC include:

• Kenneth Londoner,
  Executive Chairman of the Board, Chief Executive Officer
• Steven Chaussy,
  Chief Financial Officer
• Kenneth L. Londoner M.B.A., MBA,
  Founder, CEO & Exec. Chairman
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Lead Independent Director
• Martha Pease,
  Independent Director
• Andrew Filler,
  Independent Director
• David Weild,
  Independent Director
• Patrick Gallagher,
  Independent Director
• Donald Foley,
  Independent Director
• Anthony Zook,
  Director
• Manasi Patwardhan,
  Director of Strategic Planning
• Olivier Chaudoir,
  Senior Director of Marketing
• Julie Stephenson,
  Vice President - Clinical Affairs, Senior Director of Clinical Affairs
• Andrew Ballou,
  Vice President - Investor Relations
• John Kowalski,
  Vice President - Sales
• John Sieckhaus,
  Chief Operating Officer
• Gray Fleming,
  Chief Commercial Officer
• Steven Chaussy,
  Chief Financial Officer
• Natasha Drapeau,
  Exec. VP
• Brenda Castrodad,
  Director of HR
• Lora Mikolaitis,
  VP of Admin.
• Dr. Budimir S. Drakulic Ph.D.,
  Chief Scientist
• Steven Eric Abelman,
  Director
• Steve Chaussy,
  Chief Financial Officer
• Roy T Tanaka,
  Director
• Lora Mikolaitis,
  10% owner
• Seth H. Z. Fischer,
  Director
• Joseph Rafferty,
  Chief Commercialization Offcr
• Jerome B Zeldis,
  Director
• Asher Holzer,
  Director
• Gregory D Cash,
  President and CEO
• James L Klein,
  Director
• James J Barry,
  Director
• John Sieckhaus,
  Chief Operating Officer
• Gray Fleming,
  Chief Commercial Officer
• Steven J Buhaly,
  Chief Financial Officer
• Frederick Hrkac,
  Director
• Donald Browne,
  Director
• Christopher Allen Baer,
  Director